Symrise

Food & nutrition / Flavours and fragrance

🚀 Founded 2003 🌎 Germany 🏷️ SYIEF DE000SYM9999 ⭐ 1000 DCF 109.19 💰109.84

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights 🏢 Company Q&A (464) 🛠️ Industry Q&A (98) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

⚖️ Balance Sheet 💵 Income Statement 🔄 Cash Flow 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

📢 Press Releases

[ Disclaimer ]

Date	Press release
2025-02-21 02:30:00	Hofseth Biocare Asa: Hbc Accelerates In Human Health And Pet Nutrition Through A Strategic Partnership With Symrise To Build Out BerkÅk, Tripling The Manufacturing Capacity Of The Group Hbc will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in berkÅk, norway. symrise will support the financing of the project through a eur 5m loan. the partnership ideally complements both hbc and symrise’s current portfolio with science-led, clinically proven marine ingredients for consumer health. hbc have also signed an exclusive distribution agreement for omego®, progo® and nt-ii™ into the consumer health and functional food categories for four of symrise’s global key accounts.

Date

Press release

2025-02-21 02:30:00

Hofseth Biocare Asa: Hbc Accelerates In Human Health And Pet Nutrition Through A Strategic Partnership With Symrise To Build Out BerkÅk, Tripling The Manufacturing Capacity Of The Group
Hbc will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in berkÅk, norway. symrise will support the financing of the project through a eur 5m loan. the partnership ideally complements both hbc and symrise’s current portfolio with science-led, clinically proven marine ingredients for consumer health. hbc have also signed an exclusive distribution agreement for omego®, progo® and nt-ii™ into the consumer health and functional food categories for four of symrise’s global key accounts.

📰 Browse additional press releases for Symrise!

📚 Your free copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks" is waiting

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.